Carprofen antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Diagnostic anti-Carprofen antibodies (anti-Carprofen) and diagnostic hapten-carrier conjugates BSA-Carprofen, OVA-Carprofen, KLH-Carprofen antigens for Inflammation/autoimmune/inflammatory disease Carprofen detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Inflammation/autoimmune/inflammatory disease diagnostics products collection>>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Carprofen

OVA-Carprofen

Anti-human Carprofen mouse monoclonal antibody (mAb)

Anti-human Carprofen human monoclonal antibody (mAb)

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. Carprofen (CP), its Role in In Vitro Diagnosis (IVD):** Carprofen, an illustrious member of the non-steroidal anti-inflammatory drug (NSAID) family, commands a significant presence in the landscape of veterinary medicine. Recognized for its potent anti-inflammatory and analgesic properties, Carprofen has become an invaluable asset in alleviating pain and inflammation, particularly in companion animals. However, within the ambit of in vitro diagnosis (IVD), Carprofen transcends its traditional therapeutic application and assumes a pivotal role as a target molecule for diagnostic assays. Our company specializes in providing a comprehensive suite of anti-Carprofen antibodies and small molecule competitive antigens, embracing a spectrum of variants such as Carrier-coupled antigens, immunogens, hapten-carrier conjugates, Bovine Serum Albumin (BSA)-conjugated, and Ovalbumin (OVA)-conjugated forms. Each of these meticulously crafted reagents is tailored to enable precise Carprofen detection within a myriad of complex sample matrices.

2. **Significance of Measuring Carprofen:**

   a. **Therapeutic Drug Monitoring (TDM):** The precise measurement of Carprofen assumes paramount importance in the realm of veterinary medicine, specifically within the purview of Therapeutic Drug Monitoring (TDM). TDM embodies a strategic approach to patient care, involving the systematic monitoring of Carprofen levels in animals undergoing therapy. This practice is instrumental in ascertaining the therapeutic efficacy of Carprofen while mitigating potential risks associated with inadequate dosing or adverse effects. In essence, TDM empowers veterinarians to calibrate treatment regimens in a manner that optimizes patient care, ensuring the well-being of their animal companions.

   b. **Veterinary Clinical Management:** The routine measurement of Carprofen levels forms an indispensable component of veterinary clinical management. It offers a comprehensive view of treatment compliance and effectiveness, allowing healthcare providers to fine-tune dosage regimens and evaluate the progress of Carprofen therapy. This data-driven approach is pivotal in delivering the highest standard of care, as it enables veterinarians to make informed decisions concerning treatment adjustments, ultimately enhancing the quality of life for their animal patients.

   c. **Safety and Efficacy:** The meticulous measurement of Carprofen is a cornerstone of treatment safety and efficacy. It affords veterinarians the ability to strike a delicate balance between harnessing the therapeutic benefits of Carprofen and mitigating potential side effects. This equilibrium is crucial in ensuring that animals receive optimal care, free from undue discomfort or harm, thereby fostering a positive and efficacious treatment experience.

   d. **Research and Development (R&D):** Carprofen detection extends its sphere of influence beyond the clinical setting and permeates the realm of pharmaceutical Research and Development (R&D). Within this context, the precise measurement of Carprofen is instrumental in the evaluation of novel drug formulations and innovative drug delivery systems. Researchers and pharmaceutical scientists leverage Carprofen assays to assess the bioavailability, pharmacokinetics, and efficacy of new formulations. This rigorous evaluation process, facilitated by Carprofen detection, is pivotal in driving advancements in therapeutic outcomes and pharmaceutical innovation.

   e. **Forensic and Toxicological Investigations:** Carprofen testing holds pertinence in forensic and toxicological analyses, particularly within the domain of veterinary medicine and animal welfare. In forensic scenarios, Carprofen detection may be employed to resolve cases of suspected animal poisoning or misuse of medications. Additionally, in toxicological investigations, it aids in determining the presence of Carprofen in biological specimens, thereby assisting in the establishment of causality in cases involving adverse drug reactions or unexplained clinical symptoms.

In summation, the precise measurement of Carprofen is an indispensable facet of veterinary medicine and beyond, traversing a multifaceted landscape of clinical care, research, and forensic investigations. The specialized anti-Carprofen antibodies and competitive antigens offered by our company are designed with meticulous attention to detail, aligning with the highest standards of scientific rigor and precision. These reagents empower practitioners, researchers, and diagnosticians to conduct Carprofen assays with unparalleled accuracy and reliability, thereby contributing to the enhancement of veterinary care, scientific knowledge, and data-driven decision-making.

About GDU